| GTO ID | GTC0449 |
| Trial ID | NCT03615313 |
| Disease | Advanced Solid Tumor |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MESO CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | PD-1 Antibody Expressing mesoCAR-T Cells for Mesothelin Positive Advanced Solid Tumor |
| Year | 2018 |
| Country | China |
| Company sponsor | Shanghai Cell Therapy Research Institute |
| Other ID(s) | SHSY-IEC-4.0/18-09/02 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||||||
|
|||||||||||||||